Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia

被引:0
|
作者
Tressler, Stacy [1 ,2 ]
Lilly, Christa [3 ]
Gross, Diane [1 ,2 ]
Hulsey, Thomas [1 ]
Feinberg, Judith [4 ,5 ,6 ]
机构
[1] West Virginia Univ, Dept Epidemiol, Morgantown, WV 26506 USA
[2] Monongalia Cty Hlth Dept, Morgantown, WV USA
[3] West Virginia Univ, Dept Biostat, Morgantown, WV 26506 USA
[4] West Virginia Univ, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA
[5] West Virginia Univ, Dept Neurosci, Morgantown, WV 26506 USA
[6] West Virginia Univ, Dept Med, Div Infect Dis, Morgantown, WV 26506 USA
关键词
IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; RECOMMENDATIONS;
D O I
10.1016/j.amepre.2020.05.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: West Virginia leads the nation with the highest rate of acute hepatitis B. From 2013 to 2015, the West Virginia hepatitis B Vaccination Pilot Project distributed more than 10,000 doses of hepatitis B vaccine to at-risk adults through local health department clinics and through outreach to correctional facilities and substance use treatment centers. This study aims to determine which setting type is associated with the greatest likelihood of at-risk adults receiving all 3 or at least 2 doses of hepatitis B vaccine. Methods: Data for this retrospective cohort study were accessed, extracted, and analyzed in 2019 from Pilot Project participant forms initially completed from 2013 to 2015. Odds of receiving all 3 or at least 2 doses were calculated using bivariate, multivariable, and mixed-effects regression models. Results: Data were available for 1,201 participants. In multivariable logistic regression, participants vaccinated at substance use treatment centers (AOR=1.37, 95% CI=1.01, 1.86) and local health department family planning clinics (AOR=3.74, 95% CI=1.98, 7.06) were more likely to receive the 3-dose series versus those vaccinated at local health department sexually transmitted disease clinics. Participants vaccinated through substance use treatment centers (AOR=1.79, 95% CI=1.31, 2.44), correctional facilities (AOR=3.34, 95% CI=2.09, 5.34), and local health department family planning clinics (AOR=3.97, 95% CI=1.72, 9.16) were more likely to receive at least 2 doses. Conclusions: Hepatitis B vaccination delivered at local health department family planning clinics, substance use treatment centers, or correctional facilities may increase vaccine dose completion in West Virginia. (C) 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E189 / E196
页数:8
相关论文
共 50 条
  • [21] Immunogenicity of a combined hepatitis A and hepatitis B vaccine in healthy adults
    Thoelen, S
    VanDamme, P
    Beutels, M
    Mathei, C
    Meheus, A
    [J]. HEPATOLOGY, 1996, 23 (01) : P254 - P254
  • [22] Impact of a vaccine intervention on county-level rates of acute hepatitis B in West Virginia, 2011-2018
    Tressler, Stacy R.
    Smith, Gordon S.
    Hendricks, Brian M.
    [J]. PREVENTIVE MEDICINE, 2020, 137
  • [23] Risk Factors for Group B Streptococcal Colonization among Pregnant Women in West Virginia.
    Dietz, Paul
    Coughlin, Eric
    Sebold, Dara
    Calhoun, Byron C.
    [J]. REPRODUCTIVE SCIENCES, 2017, 24 : 173A - 173A
  • [24] Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda
    Seremba, E.
    Ocama, P.
    Ssekitoleko, R.
    Mayanja-Kizza, H.
    Adams, S., V
    Orem, J.
    Katabira, E.
    Reynolds, S. J.
    Nabatanzi, R.
    Casper, C.
    Phipps, W.
    [J]. VACCINE, 2021, 39 (08) : 1265 - 1271
  • [25] Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents
    Mansfield, Lisa N.
    Silva, Susan G.
    Merwin, Elizabeth, I
    Chung, Richard J.
    Gonzalez-Guarda, Rosa M.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 61 (05) : 701 - 708
  • [26] Implementation of hepatitis B vaccine in high-risk young adults with waning immunity
    Posuwan, Nawarat
    Vorayingyong, Arnond
    Jaroonvanichkul, Vorapol
    Wasitthankasem, Rujipat
    Wanlapakorn, Nasamon
    Vongpunsawad, Sompong
    Poovorawan, Yong
    [J]. PLOS ONE, 2018, 13 (08):
  • [27] VACCINE AGAINST HEPATITIS-B - 18 MONTHS PREVENTION IN A HIGH-RISK SETTING
    MAUPAS, P
    GOUDEAU, A
    COURSAGET, P
    DRUCKER, J
    BAGROS, P
    BAUDIN, S
    GESLIN, N
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1978, 166 (1-4) : 109 - 118
  • [28] HEPATITIS-B VACCINE SERIES COMPLIANCE IN ADOLESCENTS
    KOLLAR, LM
    ROSENTHAL, SL
    BIRO, FM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (11) : 1006 - 1008
  • [29] Does hepatitis B vaccination at birth increase the likelihood of completing the hepatitis B vaccine series and the 4:3:1:3 vaccine series
    Yusuf, H
    Daniels, D
    Smith, P
    Coronado, V
    Rodewald, L
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 236A - 236A
  • [30] Hepatitis B vaccine and risk of multiple sclerosis
    DeSefano, Frank
    Weintraub, Eric S.
    Chen, Robert T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (06) : 705 - 707